Page 4 - Extracts Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pure Extracts Enters Into Biomass Purchase Agreements To Support Oil Extract Production Pure Extracts Technologies Corp. VANCOUVER, British Columbia, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, is pleased to announce that it has entered into its first substantial biomass purchase agreements in order to scale-up its production of both THC and CBD extracts. The Company has recently agreed to purchase 220 kgs of high potency THC cannabis dried flower...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Cannabis Stocks Could See Higher Highs in 2021 CBD growth shows no signs of slowing. Retailers like Sephora, CVS, Kroger, Wegman’s, and Vitamin Shoppe are stocking shelves with it. U.S. approval ratings are increasing. In fact, a Gallup poll shows support at a new high of 68% from 66% year over year. “The latest data are from a Sept. 30-Oct. 15 poll, conducted before the election that saw marijuana legalization proposals on the ballot in several states. Voters in all of these states - Arizona, Montana, New Jersey, and South Dakota -- authorized the legal use of recreational m...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

In other industry news of note: Mydecine Innovations Group (CSE:MYCO) (MYCO.CNQ), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, recently announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries. As part of the agreement, ProPharma Group will provide regulatory advisement as the company seeks approval from the Food and Drug Administration (FDA) for it...